B A C K G R O U N D Description of the condition
The global burden of mental illness is high (WHO 2001; Prince 2007) . The WHO global burden of disease report has shown that mental and neuropsychiatric disorders account for 31.7% of all years lived with disability, the highest contributors being unipolar depression and substance use disorders (Mathers 2006 ). This burden is predicted to increase; self-inflicted injuries and alcohol related disorders are predicted to increase in the ranking of disease burden due to the decline in communicable diseases and because of a predicted increase in war and violence. Alzheimer's disease will become more common with a predicted demographic transi-tion towards an aging population and increases in life expectancy (Mathers 2006) . These illnesses also come with substantial economic costs. Estimates suggest that mental disorders in the USA account for 2.5% of the gross national product (Rice 1990) ; in the Netherlands mental disorders account for 23.2% of the health services costs (Meerding 1998); and in the UK these account for 22% of inpatient costs (Patel 1998). Data remain poor on the economic costs for low-and middle-income country (LMIC) settings (Hu 2006) . The economic and social costs for individuals and families are also substantial. High direct costs are incurred in countries where health spending is met largely through private, as opposed to public, spending and where health insurance and employermet health payments are insubstantial. High indirect costs are also incurred due to informal care-giving and lost work opportunities, as well as due to untreated disorders and their associated disability 
Description of the intervention
Non-specialist health workers (NSHWs) are first level providers who have received general rather than specialist mental health training. Cadres included are professionals (doctors, nurses and other general paraprofessionals) and non-professionals (such as lay providers). They do not include, for example, psychiatrists, psychologists, psychiatric nurses or mental health social workers. Included in this review are also other professionals with health roles (OPHRs) such as teachers and community-level workers -a further human resource used in delivering mental health care. These 
How the intervention might work
In many LMICs, training and sustaining sufficient numbers of specialists is not feasible in the near future. It is therefore important in these settings to consider options for expanding first-level access to mental health services. The use of NSHWs, who are a far more numerous than specialists, is one such option that is of high relevance to LMICs. Training these NSHWs to deliver mental health interventions may be a way of shifting tasks from specialists to non-specialists and so expanding provision of mental health services as well as making these services more accessible to communities. NSHWs may both substitute for specialists for some health issues and in some settings, and extend mental health services in settings where these are currently not widely available. It has been suggested that interventions that rely on NSHWs could deliver at least equally effective and acceptable general health and mental health interventions to those delivered by specialist health . NSHW interventions often have a lower up-front cost compared with reliance on professional specialist health workers. However, this evaluation seeks to see whether these savings may be cancelled out by higher downstream resource use, as previously noted by Chisholm 2000. The differences between LMICs and high income countries with regard to the availability of specialist health workers, the organisation and resourcing of mental health services, and other contextual differences suggest that it will be useful to review separately the effectiveness of mental health interventions in LMICs.
Why it is important to do this review
The ongoing and growing shortages of specialist human resources for health in LMICs has made the need to involve non-specialists in mental healthcare provision more urgent. Reliable evidence is needed on the effectiveness of NSHWs and OPHRs in scaling up effective community mental health interventions, including for the detection, treatment and rehabilitation of mental health problems. It is also important to assess the opportunity costs to the health system, and to the process of care for other conditions, of task-shifting or expanding NSHWs' roles within mental health (McPherson 2006; Chopra 2008; ) . This systematic review fills a gap in the knowledge of the effectiveness of NSHWs in mental healthcare provision. A better understanding of these issues would support policy development for the implementation and the sustainable scaling up of community mental health services in LMICs (Cohen 2003; Murthy 2008). The intention of this review is to examine not only what interventions are effective in first-level settings, but also which cadres of healthcare providers can effectively deliver different aspects of interventions (for example within prevention, education, detection, treatment, follow-up and rehabilitation).
O B J E C T I V E S Overall objective:
In order to assess the impact of delivery by non-specialist health workers (NSHWs) and other professionals with health roles (OPHRs) on the effectiveness of mental healthcare interventions in low-and middle-income countries (LMICs), we will specifically analyse the effectiveness of NSHWs and OPHRS in delivering acute mental health interventions; as well as the effectiveness of NSHWs and OPHRs in delivering long term follow-up and rehabilitation for people with mental disorders; and the effect of the detection of mental disorders by NSHWs and OPHRs on patient and health delivery outcomes. For each of these objectives we will examine the current evidence for the impact of delivery by NSHWs and OPHRs on the resource use and costs associated with mental healthcare provision in LMICs.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include randomised controlled trials (RCT), non-randomised controlled trials (NRCT), controlled before-after studies (CBA) and interrupted time series studies (ITS). We will only include CBAs with at least two control sites and two intervention sites. We will include controlled and non-controlled ITS that have at least three time points before the intervention and three time points after the intervention (as per the Cochrane Effective Practice and Organization of Care (EPOC) review group criteria) (Ballini 2010). We will include only studies conducted in LMICs.
For the detection component of the review, we will include studies involving direct comparisons of NSHWs/OPHRs (for example, in detecting mental disorders, or problems arising during the course of illness/care such as problems with compliance) and mental health specialists or usual care. The variable that we will consider for this review is not the accuracy of diagnosis but the outcomes for the patient and the health provider. We will not decide on inclusion of studies based on whether a reference or validated standard measure (either a screening instrument or psychiatric assessment) has been used to differentiate the outcomes between those correctly and incorrectly diagnosed by NSHWs but this will feature as part of the assessment of the quality of evidence and will be submitted to sensitivity analysis. We will also include economic studies conducted as part of included effectiveness studies. These may be full economic evaluations (cost-effectiveness analyses, cost-utility analyses or costbenefit analyses), cost analyses or comparative resource utilisation studies. We will extract and report only cost and resource usage outcomes from these studies.
Types of participants
We will include adults with mental health problems (mental, neurological and substance abuse disorders) in LMICs seeking firstlevel care/primary care or those detected in the community. We will define adults as individuals of 18 years of age and older. We will also include children and adolescents with mental health problems in LMICs seeking first-level care or those detected in the community. We will define children and adolescents as individuals who are under 18 years of age. Additionally we will include caregivers of patients with mental health problems (as some of the interventions may be directed more at the caregivers than at the patients themselves, for example interventions related to helping with drug concordance, improving the family's understanding of a condition to improve the acceptance of a person with a mental disorder etc). (See Table 1 for further definitions of LMIC, primary care and prevention)
Types of interventions
Clinical, service and social interventions delivered in primary care or the community by NSHWs or by teachers, teaching assistants and OPHRs, and intended to improve mental health. (See Table  1 for definitions of OPHR and NSHW). We will include interventions delivered for both acute mental health problems and for longer term issues. NSHW acute interventions could include various forms of psychotherapy or of pharmacological treatment. NSHW long-term interventions would include roles in follow-up or rehabilitation of people with chronic severe mental disorders, and also their roles in detecting and dealing with relapse/recurrence, compliance issues, side effects of treatment, or arising psycho-social problems.
We will consider the provision of mental health care by NSHWs/ OPHRs with some mental health training compared to usual/no care; provision of mental health care by NSHWs/OPHRs trained and supervised in mental health care (i.e. the highest level of training for NSHWs) compared to mental health specialists in primary care and the community; provision of mental health care by NSHWs/OPHRs with some mental health training compared to non-trained NSHWs/OPHRs. We will investigate the detection of mental health problems and we will include studies that consider the effect of screening, case-finding or detection by NSHWs (with some training in mental health) on subsequent patient and health provider outcomes, compared to NSHWs not actively detecting cases, or where the detection is done by specialists. The identification methods used by NSHWs could include 'naturalistic' detection (i.e. detection in a non-formal way during a clinical consultation), or detection using a validated screening/ detection tool. We will not examine diagnostic accuracy between these NSHWs and specialists as this is likely to be confounded by the screening/detection tools used. It would therefore be difficult to tell apart the effect of the screening tool from the skills of the health worker (specialist or non-specialist).
Types of outcome measures Primary outcomes
Improvement of symptoms (e.g. level of anxiety, depression, psychosis). General psycho-social functioning (e.g. levels of self esteem, perception of coping, quality of life outcomes). Disability improvement (e.g. level of dependency, self-care ability).
Secondary outcomes

For studies evaluating the detection of mental disorders and the delivery of acute and chronic mental health interventions
Patient/carer-oriented outcomes and societal outcomes
Patient or carer satisfaction and involvement in decision making processes. Patient health behaviour outcomes: such as rates of patient adherence or treatment/follow-up compliance. Adverse clinical outcomes: such as adverse effects rates, suicide/deliberate self harm rates, relapse or recurrence. Carer and social outcomes: such as return to work, offending rates, patient or carer perception of social inclusion.
Health provider and service delivery related outcomes
Measures of changes in management (such as referral rates, prescribing patterns and appropriateness). Measures of health worker behaviour (such as improvement in knowledge/skills, attitude/acceptability, retention rates, absenteeism). Measures of service delivery change (such as number of supervision sessions, hospital admission/readmission rates, utilisation of primary level services, effect on other health services provided).
For studies of costs and resource use
Direct and indirect costs to the patient and health services (including opportunity costs). Resource use (such as the patient's lost productivity, and health service personnel's time allocated/number of consultations). We have compiled these outcomes by reviewing the Cochrane Consumers and Communication Review Group's outcome taxonomy developed at LaTrobe University (La Trobe 2008), and through consultation with co-reviewers and service users. The economic outcome measures have been informed by the CCEMG 2010 training material and discussion with co-conveners. We will include only the measures which are related to resource use and costsin this review. We recognise that costs and resource use are intertwined but will divide the outcomes in this way to make it clear which outcomes we intend to measure. Where studies report more than one measure for each relevant outcome, we will abstract the primary or main measure (as defined by the study authors). We will separately document other measures as necessary.
Search methods for identification of studies Electronic searches
We will search for eligible studies in the following electronic databases:
• • Science Citation Index and Social Sciences Citation Index will be searched for papers which cite key studies, including studies included in the review We will incorporate methodological components of the Cochrane Highly Sensitive Search Strategy and the EPOC search strategy, combined with selected index terms and free text terms relating to NSHWs and mental health in our search strategies. We will search for eligible studies in any language and without any time limits. (See Appendix 1 for our MEDLINE search strategy).
Searching other resources
We will search the following:
• The metaRegister of Controlled Trials (mRCT) (http:// www.controlled-trials.com/mrct/);
• The WHO's International Clinical Trials Registry Platforms Search Portal (http://apps.who.int/trialsearch/) for ongoing trials;
• The reference lists of existing reviews (De Vet 2008);
• Grey literature will be sought from experts and will also be searched for in OpenSIGLE: http://opensigle.inist.fr/.
We will retrieve potentially eligible economic analyses when screening records generated from searches of general biomedical databases. We will retrieve economic outcome data from the identified effects studies. Initially we will not search specialised economic databases. However, once we have identified the set of economic studies that meet the inclusion criteria, we will check for a structured abstract in NHS EED (full economic evaluations only) or a structured record in HEED (full economic evaluations and cost analyses). We will use these abstracts to act as a check. We will source full text papers for data extraction. We will also contact the authors of all included effects studies for information on any published or unpublished economic studies related to their trials. We will scan reference lists of eligible trials and economic analyses (where these are reported separately to the eligible trials) for further eligible studies.
Data collection and analysis
Selection of studies
At least two authors will screen the records obtained from the searches. We will retrieve full text copies of all articles identified as potentially relevant by at least one review author. Two authors will independently evaluate each full paper for inclusion. Two review authors will resolve disagreements on inclusionby discussion. If no agreement can be reached, we will ask a third author to make an independent assessment. Where appropriate, we will contact the study authors for further information.
Data extraction and management
Two authors will independently extract descriptive and outcome data for each paper using an adapted version of the EPOC data collection checklist. Review authors will obtain any missing data by contacting trial authors. Two authors (NvG and PT) will doubleenter the checked data into RevMan for meta-analysis. We will extract the following information for all included studies that evaluate interventions. Details of the intervention: the type and length of each of the clinical, social and service interventions; a full description of cadre(s) of NSHW consulting with the patient including details of their training and supervision/support; and the length, frequency and type of intervention delivered by each NSHW; description of the specialist providing care (type, experience, training in using reference standard). Participants: a full description of the patients (sex, age, socio-economic status, ethnicity) including details of the mental health condition being treated. Setting: country; type of health service (e.g. publicly funded, NGO etc), organisation of the primary care and specialist services; specialist outreach or generalist. Results: organised into patient, provider and process outcomes (see above). In addition, for non-randomised trials we will record whether the study restricted participant selection, and/or demonstrated balance or matching between intervention and control groups on prognostic factors. An imbalance of these may act as confounders (such as age, sex, socio-economic status). We will also record whether the study adjusted for confounders in statistical analyses to quantify the effect size Reeves 2009. We will enter these assessments into additional tables. For studies assessing detection of mental illness, we will also extract the following information. Details of the screening instrument or procedure(s) used by nonspecialists: (where relevant) whether validated and citation details; if translated, language of translation and methods used; if modified from the original, details of modifications such as number of items or content change; cut off thresholds used; self rated or observer rated. Details of the reference standard used by specialists: structured questionnaire/interview and publication details; diagnostic criteria used and citations; whether modified and details of any modifications. Pre-study procedures: (where relevant) methods used to address inter-observer variation and in selecting threshold values. Study procedures: sampling technique; time period between nonspecialist and specialist assessments; independence of classifying those with and without disorder by specialists and non-specialists.
Assessment of risk of bias in included studies
Two authors will independently assess eachstudy for risk of bias. This assessment will be informed by the following.
• The Cochrane Handbook for Systematic Reviews of Interventions 'risk of bias' tool (sequence generation, allocation concealment, blinding of participants, personnel and outcome assessors, incomplete outcome data, selective outcome reporting, other sources of bias). Our judgements on the risk of bias -that is to decide whether the study is at high, unclear or low risk of bias -will be based on assessing the conduct of the study rather than the reporting of it (Higgins 2009).
• Additional criteria developed by the Cochrane EPOC group (Ballini 2010) to assess risk of bias for each of the study designs (RCT, CBA, NRCT, ITS). Such criteria include followup of professionals, follow-up of patients or episodes of care, baseline measurement, and protection against contamination.
• For economic studies, we will use the CHEC criteria list (see Appendix 2).
We will incorporate risk of bias assessments by generating 'risk of bias' summary graphs and figures using RevMan 2008 and by incorporating these judgements in evaluating study limitations while preparing GRADE 'Summary of findings' tables.
Measures of treatment effect
Measures of intervention effect regarding clinical, service and social interventions
For dichotomous outcomes we will use risk ratios, for continuous outcomes we will use the mean difference. We will express all effect estimates with their 95% confidence intervals (CI). We will transform ordinal outcomes (such as symptom severity, general psychosocial functioning, levels of dependency in disability, and any other outcomes measured on a scale) into binary data (for example symptom improvement will become improvement or no improvement). For specific outcomes, if eligible studies report mainly continuous data, we will use continuous data for the main analysis, and vice versa if the outcomes are predominantly expressed as dichotomous data. Where studies report predominantly dichotomous data for specific outcomes, we will manage any continuous data for these outcomes as follows. 1. If the studies that report continuous data use the same scales or instruments as those used for the studies reporting dichotomous data, we will transform the continuous data to dichotomous data using the cut-offs used in the studies reporting dichotomous data. 2. If the studies that report continuous data do not use the same scales or instruments as those used for the studies reporting dichotomous data, we will convert any continuous data for those outcomes to dichotomous data using the methods described in Deeks 2009. We will then express the pooled results for the dichotomous and transformed continuous data as odds ratios and absolute measures by using the formula SMD=( √ 3/π) In OR (Chinn 2000). This will allow us to pool dichotomous and continuous data in one meta-analysis. If one or more studies included in a meta-analysis report data either on a continuous scale or a dichotomous scale and in either scenario have been transformed, the transformed data will be excluded in sensitivity analyses.
Measures of effect of detection of mental disorders interventions
We will report the effects of detection of mental disorders by NSHWs or OPHRs in several ways: we will measure the patient outcome by looking at the proportion of patients who recover or improve over a specific length of time determined by the eligible studies. We will measure health worker outcomes by the change in prescribing rates, referral rates and treatment initiation rates.
Unit of analysis issues
If possible we will re-analyse studies that randomise or allocate clusters (patients, health professionals, healthcare settings or geographical areas) but do not account for clustering in their analysis (Ukoumunne 1999). We will attempt to adjust the results for clustering by multiplying the standard errors of the estimates by the square root of the design effect where the design effect is calculated as DEff = 1 + (M -1) ICC, where M is the average cluster size and ICC is the intra-cluster correlation coefficient. We will combine the adjusted measures of effects of cluster-randomised trials with the results of non-cluster trials, if it is possible to adjust adequately the results of the cluster trials. We will also perform sensitivity analyses on meta-analyses including cluster randomised trials in which we compare the effects estimates with and without the inclusion of the cluster trials. We will contact authors if more information is needed for the analysis. Where no information on the intra-cluster correlation coefficient (ICC) is reported, we will extrapolate the ICC from other cluster RCTs, if available (Campbell 2000). If this is not possible, we will not combine the findings of these studies in a meta-analysis, but will present the results in an additional table.
Dealing with missing data
If information is missing or unclear, the authors will contact the study investigators for clarification or additional information. To reduce the risk of overly positive answers, we will use open-ended questions (as recommended in the Cochrane Handbook, Higgins 2009). Where possible, we will extract data to allow an intention-to-treat (ITT) analysis in which all randomised participants are analysed in the groups to which they were originally assigned. We will calculate the percentage loss to follow-up in each group and report this information if there are discrepancies between the numbers randomised and the numbers analysed in each treatment group. We will assign the worse outcome to those lost to follow-up for dichotomous outcomes and assess the impact of this in sensitivity analyses, where the available cases are used as the basis for analysis. For studies that report continuous data but do not report standard deviations, we will either calculate these from other available data such as standard errors, or impute these using the methods suggested in Higgins 2009. We will not make any assumptions about loss to follow-up for continuous data and we will analyse results for those who complete the trial.
Assessment of heterogeneity
Statistical heterogeneity assesses observed intervention effects are more different from each other than one would expect due to random error (chance) alone. We will obtain an initial visual overview of heterogeneity through scrutinising the forest plots, looking at the overlap between confidence intervals around the estimate for each included study. To quantify the inconsistency across studies, and thus the impact of heterogeneity on the meta-analysis, we will use the I² statistic, but only if the number of studies is significant enough to detect heterogeneity. In the latter case, we will define an I² of > 50% as revealing substantial heterogeneity. We will also interpret the significance of the I² test in light of (i) the magnitude and direction of effects and (ii) the strength of evidence for heterogeneity (for example a confidence interval for the I², or the P value as compared to the Chi 2 test).
Assessment of reporting biases
To reduce possible publication bias, we will employ strategies to search for and include relevant unpublished studies. These strategies will include searching the grey literature and prospective trial registration databases to overcome time-lag bias. We will use funnel plots to 'eyeball' whether there is asymmetry, though this does not indicate publication bias. If we find more than 10 studies in this review, we will consider statistical testing for funnel plot asymmetry. For continuous outcomes with intervention effects measured as mean differences, we will use the test proposed by Egger 1997 to test for funnel plot asymmetry. For dichotomous outcomes with intervention effects measured as odds ratios, we will use the test by Rücker 2008 as, due to the nature of this review, heterogeneity variance is expected to be high. For dichotomous outcomes with intervention effects measured as risk ratios, and continuous outcomes with intervention effects measured as standardised mean differences, we will not consider funnel plot calculations because funnel plots using risk differences are seldom of interest.
We will interpret the results of tests for funnel plot asymmetry in the light of visual inspection of the funnel plot, as the statistical results may not be representative if there are small-study effects.
Data synthesis
For each comparison, we will report tables of summary statistics for each of the included studies (RCTs, NRCTs, CBAs and controlled/non-controlled ITSs). These tables will include study design, baseline and follow-up summary statistics, effect estimates and their statistical significance, and, if available, information on effect modifiers. We will use forest plots to display the data graphically. We will first assess observable heterogeneity amongst the study questions and methods to determine whether meta-analysis is appropriate. We will also look at the study participants, settings, interventions, and reported outcomes. We will pay particular attention to the homogeneity of methodology (such as variances in blinding and concealment of allocation) within and across included studies. Where the outcomes assessed and the settings and interventions are very diverse, it may not be appropriate to combine the results quantitatively. For these results, we will present a descriptive summary of data. For all data syntheses we will use the generic inverse-variance model of analysis as this allows the analysis of continuous and dichotomous data and allows clustered and non-clustered data to be combined. We will base the choice of whether to use a fixed-effect or random-effects model on the extent to which studies are similar, or homogeneous, based on their PICOS characteristics (population, intervention, comparators, outcomes and settings). If selected studies are sufficiently homogeneous, then we will apply a fixed-effect model. The most likely outcome, however, is that the studies will be heterogeneous. We will use a random-effects model in this case, unless the data are sufficiently heterogeneous (i.e. little or no homogeneity in their PICOS) that any kind of meta-analysis is not appropriate.In this case we will summarise the findings within the text of the review. We shall report the results separately for RCTs and for non-randomised studies. ITS and cITS studies are often incorrectly analysed as they use statistical methods that do not account for the autocorrelation of data points (Ramsay 2003). If possible, we will use time series regression to re-analyse each comparison (Ramsay  2003) . We will use effect estimates adjusted for confounding (baseline differences in control and intervention groups) where possible, and use methods described in Reeves 2009 to guide data synthesis.
Economic data
We will conduct all the elements of the economics component of this review according to current guidance on the use of economics methods in the preparation and maintenance of Cochrane reviews (Shemilt 2009). We will classify the included economic evaluations based on an established system (Drummond 2005). We will summarise the characteristics and results of included economic evaluations using additional tables, supplemented by a narrative summary that will compare and evaluate methods used and principal results between studies. We will display resource use and cost data in a table, along with unit cost data (if this is available). A unit cost is defined as the cost of each specific resource input calculated by multiplying the measured number of units (quantities) of an item of resource use (for example the number of hours of time provided by a senior teacher) by an applicable unit cost (for example the salary cost of one hour of senior teacher time). We will report the currency and price year applicable to measures of costs and unit costs in each original study. Measures of costs are highly likely to vary across and within study settings, and over time. This is the product of variations in the underlying quantities of resource use and variations in the underlying unit costs. For studies reporting details of currency and price year, unit costs and measures of resource use in disaggregated form, we will convert unit costs to 2010 International Dollars using a web-based tool (Shemilt 2010). We will re-estimate costs by multiplying the measured quantity of each resource by the adjusted unit cost. If details of the original price year cannot be collected, we will contact the study author for such information; failing this we will use rational assumptions to infer the price year. If unit costs and measures of resource use are not reported separately we will instead convert estimates of costs to 2010 International Dollars using the same methods. We will undertake adjustments for currency and price year in order to facilitate a meaningful comparison between estimates of costs and unit costs collected from studies conducted in different settings and at different times. We will calculate total costs per patient by summing the adjusted costs of all measured items of resource use resulting from the intervention. We may also make an interim calculation (i.e. at a level between the cost of a specific item of resource use and total costs of an intervention)in which the costs of several items of resource use are summed to estimate the costs incurred per specific NSHW provider. Subject to the availability of requisite data, we will pool measures of resource use and costs using standard meta-analysis techniques (see 'Data synthesis' above). We will undertake the pooling of these data primarily as a vehicle to measure heterogeneity and facilitate investigation of factors contributing to variations in resource use and costs between studies (for example differences in the organisation of services between settings such as different staff grades, or different frequency of patient contacts; variations in market; economies of scale etc). We will make decisions about whether to present pooled estimates of resource use and costs based on the results of the above assessments of observable heterogeneity of studies and populations. We will focus the economics component of the review exclusively on evidence collected from economic evaluations conducted alongside eligible RCTs (and other eligible study designs, if included). We will therefore exclude any economic evaluations conducted using evidence assembled from several different sources (for example economic modelling studies). In principal, this has the potential to impact on the results of the economics component of the review.
Subgroup analysis and investigation of heterogeneity
We will perform subgroup analyses to check if the intervention effect varies with different population, intervention or setting characteristics. Each subgroup analysis will depend on having sufficient trials to perform a statistically significant comparison between groups. We will perform meta-regression to investigate both the effect of the intervention on the estimates of effects and to investigate the effect of multiple characteristics (regarding setting and the intervention) simultaneously (Deeks 2009) only if there are ten times or more observations (studies) available than the number of independent variables (characteristics). This would mean that if we want to perform meta-regression simultaneously on two independent variables we would need 20 or more studies, and so on.
If there are fewer than 10 studies per variable, for fixed-effect metaanalyses we will assess subgroup differences by interaction tests (Altman 2003). For random-effects meta-analyses we will use nonoverlapping CIs to indicate a statistically significant difference in treatment effect between the subgroups. If the decision has been taken not to perform a meta-analysis, we will summarise the results of the subgroups within the text of the review. We will analyse the following subgroups.
• by setting (low-versus middle-income countries);
• by intervention characteristics: by group of disorders (common mental disorders, severe mental disorders and substance abuse disorders) These categories fit with current models of service delivery in LMICs; by category of health worker (professionals (i.e. doctors, nurses, other professionals) and OPHRs compared with non-professionals (i.e. lay health or non-health workers));
• by types of community intervention (pharmacological, non-pharmacological, and mixed approach).
Sensitivity analysis
The carrying out of a sensitivity analysis will depend on whether the studies identified are at high or low risk of bias, or a combination of these. We will look at an initial visual impression of the impact of bias by graphing results according to risk of bias (separating out those at high-, unclear-and low-risk of bias on the forest plots). If possible, we will formally compare intervention effects according to risk of bias using meta-regression (risk ratio (RR) in studies with high and unclear risk of bias versus RR in low risk of bias studies). If there are sufficient studies identified as low risk of bias, we will restrict a primary analysis to these. We will then include the 'unclear' and 'high-risk' of bias studies in a sensitivity analysis to show how the conclusions may be affected by this inclusion. We will consider additional sensitivity analyses as follows:
• based on specific decisions made during the review process, such as how ICCs are imputed for cluster trials;
• based on whether the included cluster randomised trials find different estimates of effect to non-cluster trials for specific outcomes, bu excluding cluster randomised trials;
• based on whether the study reports a validated tool that confirms the NSHWs diagnostic accuracy;
• if one or more studies report outcomes using either a continuous scale or a dichotomous scale and in either scenario have been transformed (to dichotomous or continuous variable respectively);
• based on the effect of including or not those lost to followup, where the available cases are used as the basis for analysis.
For the economic analyses, we will conduct sensitivity analysis to explore the impact of different assumptions made with respect to price year for those studies that do not report price year (Shemilt 2010).
Summarising and interpreting results
We shall use the GRADE approach to assess the quality of evidence related to each of the key outcomes (Schünemann 2009).
We will use the GRADE profiler (GRADE 2004) to import data from Review Manager (RevMan 2008) and create 'Summary of findings' tables. For assessments of the overall quality of evidence for each outcome that includes pooled data from RCTs only, we will downgrade the evidence by one level from 'high quality' for serious (or by two for very serious) study limitations (risk of bias) that include: indirectness of evidence, serious inconsistency, imprecision of effect estimates, or potential publication bias. Data from observational studies will start at low quality, but we may upgrade this to moderate or high quality if the pooled estimates reveal a large magnitude of effect, negligible concerns about confounders, or a strong dose-response gradient. We will use these assessments, along with the evidence (or lack) for absolute benefit or harm of the interventions and the sum of available data on all critical and important outcomes from each study included for each comparison, to draw conclusions about the effectiveness of NSHWs in mental healthcare provision in low and middle income countries.
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A D D I T I O N A L T A B L E S
Adult
The cut off point will be patients who are 18 years old or above. However if some studies have an age range from, for example, 16 years upwards and the majority of participants are over 18, we would also include these study participants as adults
Children and adolescents
Children (from birth to 18 years) are considered as a separate group of participants as they have (i) different patterns of psychopathology/mental disorders; (ii) different help seeking behaviours which would therefore require; (iii) different interventions, in different settings (e.g. schools) and a different approach to care-worker interventions (such as teacher-led interventions)
Mental disorders
This review will include mental disorders as defined by any criteria within included papers. For the purpose of subgroup analysis, we will subgroup these disorders using the ICD-10 criteria for mental and behavioural disorders and epilepsy in adults (the related ICD-10 code is listed in brackets). We will subcategorise these disorders according to most likely mental health service delivery in LMIC, based on Patel's classification (Where there is no psychiatrist) (Patel 2003) and the recent WHO MNS (mental, neurological and substance abuse disorders) categorisation (WHO 2008). i. Common mental disorders Mild to moderate mood (affective) disorders (F32-38) Neurotic, stress-related and somatoform disorders (F40-49) Behavioural syndromes associated with physiological disturbances and physical factors (F50-59) ii.
Severe mental disorders Schizophrenia, schizotypal and delusional disorders (F20-F29) Bipolar affective disorder (F31) Severe depressive episode with/without psychosis (F32.2, F32.3) iii. Neuropsychiatric disorders Organic, including symptomatic, mental disorders (includes dementia) (F1-9) Mental retardation (F70-79) Epilepsy (G40) iv. Disorders caused by substance abuse First level of contact with formal health services are community based interventions and/or primary care interventions, on their own or attached to hospital settings, provided they have no specialist input apart from supervision (modified from Wiley-Exley 2007). This would include individuals with mental illness living in the community and programmes in outpatient clinics or primary care practices. This would not include programmes in hospitals unless the programmes in the hospitals were providing care to outpatients (i.e. generalists in outpatients) Community: as mentioned above detection of mental disorders in all age groups are often done outside the health facility, for example through school, training and other community settings. Therefore we will consider interventions outside the health sector LMIC Any country that has ever been a low-or middle-income country, as defined by the World Bank lists of low-and middle-income countries. If a multi-centre trial is found which includes LMICs and a few HICs, we will also include this
Non-specialist health workers (NSHWs)
Those who are not specialised in mental health or have not received in-depth professional specialist training in this clinical area. These include doctors, nurses, auxiliary nurses, lay health workers, as well as allied health personnel such as social workers, occupational therapists. This category does not include professional specialist health workers such as psychiatrists, psychiatric nurses or mental health social workers. NSHWs may have received some training in mental health, but this would not constitute a professional category. The authors will make a judgement of what constitutes 'some training'. Examples of 'some training' may be an undergraduate module or short course in mental health
Other professionals with health roles (OPHRs) These will include people who are involved as community-level workers but are not within the health sector, as many people, particularly adolescents and young adults, have low contact with health workers. This category includes teachers/ trainers/support workers from schools and colleges, and other volunteers or workers within community-based networks or NGOs. These OPHRs have an important role particularly in the promotion of mental health and detection of mental disorders (WHO 2003a; Patel 2007b; Patel 2008a). We will exclude studies which look at informal care provided by family members or extended members only to members of his or her own family (i.e. who are unavailable to other members of the community) from this review. As previously highlighted in Lewin's recent Cochrane review, "these interventions are qualitatively different from other LHW interventions included in this review given that parents or spouses have an established close relationship with those receiving care which could affect the process and effects of the intervention" (Lewin 2010).
